RAND report identifies AI-enabled biotechnology as significant bioweapon proliferation risk

A new RAND Corporation assessment concludes that AI tools lower technical barriers for the development of novel or enhanced pathogens. The report models high-consequence scenarios with potential impacts exceeding the scale of the COVID-19 pandemic, highlighting a shift in biological threat vectors.